Skip to main content
SpringerLink
Log in

NICE result for three drugs . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE recommends new treatment for people with common heart condition. Media Release : 23 Jan 2013. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE gives green light to two treatments for lung infection in adults and children over six with cystic fibrosis. Media Release : 24 Jan 2013. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE issues final guidance on treatment for bladder cancer. Media Release : 23 Jan 2013. Available from: URL: http://www.nice.org.uk

  4. NICE. NICE guidance doesn’t recommend fluocinolone implant for chronic diabetic macular oedema. Media Release : 23 Jan 2013. Available from: URL: http://www.nice.org.uk

  5. National Institute for Clinical Excellence. NICE consultation opens on drug for severe gout. Media Release : 1 Feb 2013. Available from: URL: http://www.nice.org.uk

  6. National Institute for Clinical Excellence. NICE draft guidance does not recommend bevacizumab for recurrent advanced ovarian cancer. Media Release : 1 Feb 2013. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE result for three drugs . . .. PharmacoEcon Outcomes News 671, 10 (2013). https://doi.org/10.1007/s40274-013-0145-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0145-8

Search

Navigation